BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32869705)

  • 1. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
    Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
    J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.
    Dun C; Yuan M; Zhao X; Hu S; Arbyn M; Zhao F
    Cancer Med; 2024 Jun; 13(11):e7316. PubMed ID: 38828559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
    Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
    Hanley SJB; Fujita H; Aoyama-Kikawa S; Kasamo M; Torigoe T; Matsuno Y; Noriaki S;
    J Gynecol Oncol; 2021 Nov; 32(6):e86. PubMed ID: 34708593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results.
    Zhang Y; Zhang W; Du H; Qu X; Chen Y; Wang J; Wu R
    BMC Infect Dis; 2023 Nov; 23(1):783. PubMed ID: 37950154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials.
    Zhang Y; Du H; Xiao A; Zhang W; Wang C; Huang X; Qu X; Wang J; Wu R
    Infect Agent Cancer; 2022 Jun; 17(1):27. PubMed ID: 35690793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Chatzistamatiou K; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Skenderi A; Stamatopoulos K; Agorastos T
    Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples.
    Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
    PLoS One; 2020; 15(5):e0232107. PubMed ID: 32379782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
    [No Abstract]   [Full Text] [Related]  

  • 12. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
    Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
    PLoS One; 2020; 15(5):e0232117. PubMed ID: 32357165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Adcock R; Nedjai B; Lorincz AT; Scibior-Bentkowska D; Banwait R; Torrez-Martinez N; Robertson M; Cuzick J; Wheeler CM;
    Int J Cancer; 2022 Oct; 151(7):993-1004. PubMed ID: 35477862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
    Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
    Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
    Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
    PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
    Volesky KD; Magnan S; Mayrand MH; Isidean SD; El-Zein M; Comète E; Franco EL; Coutlée F
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):851-857. PubMed ID: 35131879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
    Trzeszcz M; Mazurec M; Jach R; Mazurec K; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Wasowska J; Duczek-Polakiewicz M; Rozmus P; Streb J; Halon A
    J Med Virol; 2023 Nov; 95(11):e29271. PubMed ID: 38009626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.
    Cook DA; Krajden M; Brentnall AR; Gondara L; Chan T; Law JH; Smith LW; van Niekerk DJ; Ogilvie GS; Coldman AJ; Warman R; Reuter C; Cuzick J; Lorincz AT
    Int J Cancer; 2019 May; 144(10):2587-2595. PubMed ID: 30412281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of p16
    Song F; Belinson JL; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    Gynecol Oncol; 2021 Aug; 162(2):322-330. PubMed ID: 34059349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
    Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.